Morningside Group Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
447
- Portfolio
-
167
- Exits
-
154
Morningside Group General Information
Company Description
Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts. The firm makes venture capital investments in companies with novel science and technology. The firm is characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically. The firm's team of entrepreneurial investment professionals has experience in life sciences, digital health, AI, materials, and technology. The firm's charitable commitments to education, research, and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.
Business Details
Website
www.morningside.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1188 Centre Street
- Newton Centre
- Newton, MA 02459-0000
- United States
Morningside Group Investments & Acquisitions (447)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Synphatec | 28-Sep-2026 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| AdvanCell | 15-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Mighty Therapeutics | 14-Jul-2026 | Drug Discovery | Generating Revenue | |||
| Dermatic Health | 12-Jun-2026 | Decision/Risk Analysis | Startup | |||
| Ampa Health | 14-May-2026 | Therapeutic Devices | Generating Revenue | |||
| Valitor (Biotechnology) | 05-May-2026 | Biotechnology | Pre-Clinical Trials | |||
| SimpliFed | 07-Apr-2026 | Clinics/Outpatient Services | Generating Revenue | |||
| 3X Genetics | 25-Mar-2026 | Diagnostic Equipment | Generating Revenue | |||
| Cognito Therapeutics | 05-Mar-2026 | Later Stage VC | Therapeutic Devices | Clinical Trials - Phase 3 | ||
| Angitia Biopharmaceuticals | 27-Jan-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
Morningside Group Exits (154)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ground Signal | 13-Oct-2026 | Buyout/LBO | |
| Stavvy | 06-Oct-2026 | ||
| Evonetix | 08-Sep-2026 | ||
| Apnimed | 31-Jul-2026 | ||
| ViOptix | 15-Jul-2026 | ||
| Alebund Pharmaceuticals | 29-Jun-2026 | ||
| Pinteon Therapeutics | 29-Apr-2026 | ||
| Adjuvance | 25-Apr-2026 | ||
| Alamar Biosciences | 16-Apr-2026 | IPO | |
| EpiVax Therapeutics | 02-Apr-2026 | Out of Business |
Morningside Group Investments by Industry, Year, and Region
Morningside Group Co-Investors (307)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 5Y Capital | 5 |
|
|
||
| Alumni Ventures |
|
|
|||
| OrbiMed |
|
|
|||
| Forbion |
|
|
|||
| T. Rowe Price Group |
|
|
Morningside Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 5Y Capital | Shanghai, China | 2008 |
Morningside Group FAQs
-
What is Morningside Group?
Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts.
-
When was Morningside Group founded?
Morningside Group was founded in 1986.
-
Where is Morningside Group headquartered?
Morningside Group is headquartered in Newton, MA.
-
How many investments has Morningside Group made?
Morningside Group has made 447 investments.
-
What has Morningside Group invested in?
Morningside Group has made numerous investments in companies like Synphatec, AdvanCell, and Mighty Therapeutics within the Drug Discovery industry.
-
What has Morningside Group invested in recently?
Morningside Group's latest investment was on 28-Sep-2026 in Synphatec, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process